EE04274B1 - (R)-(+)-N-[[3-[1-bensoüül-3-(3,4-diklorofenüül)piperidiin-3-üül] prop-1-üül]-4-fenüülpiperidiin-4-üül]-N-metüülatseetamiidi (osanetandi) kristallivormid ja nende valmistamise meetod - Google Patents

(R)-(+)-N-[[3-[1-bensoüül-3-(3,4-diklorofenüül)piperidiin-3-üül] prop-1-üül]-4-fenüülpiperidiin-4-üül]-N-metüülatseetamiidi (osanetandi) kristallivormid ja nende valmistamise meetod

Info

Publication number
EE04274B1
EE04274B1 EEP200100070A EEP200100070A EE04274B1 EE 04274 B1 EE04274 B1 EE 04274B1 EE P200100070 A EEP200100070 A EE P200100070A EE P200100070 A EEP200100070 A EE P200100070A EE 04274 B1 EE04274 B1 EE 04274B1
Authority
EE
Estonia
Prior art keywords
osetane
phenylpiperidin
methylacetamide
dichlorophenyl
piperidin
Prior art date
Application number
EEP200100070A
Other languages
English (en)
Estonian (et)
Inventor
Alcade Alain
Anne-Archard Gilles
Grosclaude Patrick
Monnier Olivier
Roche J�rome
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE200100070A publication Critical patent/EE200100070A/xx
Publication of EE04274B1 publication Critical patent/EE04274B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100070A 1998-08-05 1999-08-03 (R)-(+)-N-[[3-[1-bensoüül-3-(3,4-diklorofenüül)piperidiin-3-üül] prop-1-üül]-4-fenüülpiperidiin-4-üül]-N-metüülatseetamiidi (osanetandi) kristallivormid ja nende valmistamise meetod EE04274B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9810107A FR2782082B3 (fr) 1998-08-05 1998-08-05 Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
PCT/FR1999/001914 WO2000007987A1 (fr) 1998-08-05 1999-08-03 Formes cristallines du osanetant

Publications (2)

Publication Number Publication Date
EE200100070A EE200100070A (et) 2002-06-17
EE04274B1 true EE04274B1 (et) 2004-04-15

Family

ID=9529458

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100070A EE04274B1 (et) 1998-08-05 1999-08-03 (R)-(+)-N-[[3-[1-bensoüül-3-(3,4-diklorofenüül)piperidiin-3-üül] prop-1-üül]-4-fenüülpiperidiin-4-üül]-N-metüülatseetamiidi (osanetandi) kristallivormid ja nende valmistamise meetod

Country Status (31)

Country Link
US (1) US7041679B2 (de)
EP (1) EP1102747B1 (de)
JP (1) JP3807938B2 (de)
KR (1) KR100571944B1 (de)
CN (1) CN1114592C (de)
AR (1) AR019953A1 (de)
AT (1) ATE243197T1 (de)
AU (1) AU748177B2 (de)
BR (1) BR9913357A (de)
CA (1) CA2339007A1 (de)
CO (1) CO5070576A1 (de)
DE (1) DE69908951T2 (de)
DK (1) DK1102747T3 (de)
DZ (1) DZ3074A1 (de)
EA (1) EA003205B1 (de)
EE (1) EE04274B1 (de)
ES (1) ES2200535T3 (de)
FR (1) FR2782082B3 (de)
HU (1) HUP0103134A3 (de)
IS (1) IS5821A (de)
MY (1) MY121447A (de)
NO (1) NO320645B1 (de)
NZ (1) NZ509561A (de)
PL (1) PL345999A1 (de)
PT (1) PT1102747E (de)
SK (1) SK1742001A3 (de)
TR (1) TR200100261T2 (de)
TW (1) TW527354B (de)
UA (1) UA72890C2 (de)
WO (1) WO2000007987A1 (de)
YU (1) YU8601A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
US7648992B2 (en) * 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
WO2023278843A2 (en) * 2021-07-02 2023-01-05 Acer Therapeutics, Inc. Solid forms of osanetant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
JP2000515534A (ja) * 1996-08-05 2000-11-21 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ 3,3―二置換ピペリジンの製造方法
US6040316A (en) * 1996-09-16 2000-03-21 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
HUP0103134A3 (en) 2003-03-28
US7041679B2 (en) 2006-05-09
CN1314888A (zh) 2001-09-26
US20040044215A1 (en) 2004-03-04
TR200100261T2 (tr) 2001-06-21
KR20010072220A (ko) 2001-07-31
MY121447A (en) 2006-01-28
TW527354B (en) 2003-04-11
PT1102747E (pt) 2003-09-30
NZ509561A (en) 2002-10-25
IS5821A (is) 2001-01-23
DE69908951T2 (de) 2004-05-19
ES2200535T3 (es) 2004-03-01
KR100571944B1 (ko) 2006-04-18
AU5168599A (en) 2000-02-28
DE69908951D1 (de) 2003-07-24
AR019953A1 (es) 2002-03-27
CN1114592C (zh) 2003-07-16
FR2782082A1 (fr) 2000-02-11
HK1035535A1 (en) 2001-11-30
SK1742001A3 (en) 2001-11-06
EA003205B1 (ru) 2003-02-27
JP3807938B2 (ja) 2006-08-09
CA2339007A1 (en) 2000-02-17
DZ3074A1 (fr) 2004-07-20
EP1102747A1 (de) 2001-05-30
DK1102747T3 (da) 2003-09-29
JP2002522419A (ja) 2002-07-23
FR2782082B3 (fr) 2000-09-22
NO320645B1 (no) 2006-01-09
NO20010553D0 (no) 2001-02-01
CO5070576A1 (es) 2001-08-28
EE200100070A (et) 2002-06-17
WO2000007987A1 (fr) 2000-02-17
HUP0103134A2 (en) 2002-06-29
EP1102747B1 (de) 2003-06-18
UA72890C2 (en) 2005-05-16
BR9913357A (pt) 2001-05-15
PL345999A1 (en) 2002-01-14
ATE243197T1 (de) 2003-07-15
NO20010553L (no) 2001-04-05
EA200100096A1 (ru) 2001-08-27
AU748177B2 (en) 2002-05-30
YU8601A (sh) 2003-07-07

Similar Documents

Publication Publication Date Title
FI972037L (fi) Parannettu menetelmä syötävien pakkausten valmistamiseksi ja koostumuksia niitä varten
FI972309L (fi) 2-heterosyklyylioksi- ja tiometyyli-1,2,5-tiaditsolidin-3-oni-1,1-dioksideja, niitä sisältäviä koostumuksia ja menetelmä niiden valmistamiseksi
DE69612185D1 (de) Bleichverfahren und bleichmittelzusammensetzung
DE59903302D1 (de) Verfahren und spinnmaschine zum herstellen von coregarn
DE69517843D1 (de) Weiche Süssware und Herstellungsverfahren
IT1289532B1 (it) Composti, di cloridrato di paroxetina e procedimenti per la loro preparazione
NO953658D0 (no) Fremgangsmåte for fremstilling av 3-[4-(2-aminoetoksy)-benzoylÅ-2-aryl-6-hydroksybenzo[bÅtiofener
DE69536084D1 (de) Halbleiterbauelement und Verfahren zu seiner Herstellung
DE69615361D1 (de) Melkverfahren und melkmaschine
NO20005202L (no) Fremgangsmåte for fremstilling av börstevarer og börstevarer fremstilt ifölge fremgangsmåten
DE69938533D1 (de) Trägheitssensor und Verfahren zu seiner Herstellung
EE200100070A (et) (R)-(+)-N-[[3-[1-bensoüül-3-(3,4-diklorofenüül)piperidiin-3-üül] prop-1-üül]-4-fenüülpiperidiin-4-üül]-N-metüülatseetamiidi (osanetandi) kristallivormid ja nende valmistamise meetod
DE69419922D1 (de) Verfahren zum kontinuierlichen Conchieren von Schokolade
DE19604279B4 (de) Einsatzwerkzeuge für Bohrhämmer und Verfahren zu seiner Herstellung
DE69926978D1 (de) Flüssigkeitsgefüllter Schwingungsisolator und ein Verfahren zu seiner Herstellung
DE69914820D1 (de) Verbindungshalbleiter-Kristall und Verfahren zu seiner Herstellung
BR9402627A (pt) Processo de destalar manocas e máquina destaladeira
FI972055A0 (fi) Syljen analysointimenetelmä
FI972310L (fi) Substituoituja 2-(fosfinyylioksimetyyli-1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja, niitä sisältäviä koostumuksia ja menetelmä niiden käyttämiseksi
NO974846D0 (no) Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid
IT1283793B1 (it) Processo per la preparazione di diidropiridine
MD186B1 (ro) Metoda de tratament al endometritei dupa operatia cezariana
ID23645A (id) Proses pembuatan fenoksifenilsulfonil halida
FI955327A0 (fi) Parannettu menetelmä BMS 180048:n ja sen analogien suurimittakaavaista tuotantoa varten
ID30118A (id) Proses pembuatan turunan-turunan daeza-adenosin tersubstitusi-n6

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20070803